Bernstein: Automakers Accelerate Humanoid Robot Deployment, Blue-Collar Job Replacement Timeline Emerges
N.R. Finch
Bernstein analyst Eunice Lee argues that automakers from Tesla to BYD are leveraging manufacturing scale and autonomous-driving expertise to build a structural first-mover edge in humanoid robots, with 2026–2027 shaping up as the first mass-production window — and a blue-collar job-replacement timeline coming into view.
Why can automakers outrun pure tech firms here?
Cars and humanoid robots share core hardware — motors, reducers, sensors — giving OEMs a built-in supply-chain advantage.
Lee writes: automakers are entering the field "both to boost production efficiency and to open new revenue streams."
This means → they are not dabbling in a new market. They are shifting existing manufacturing capability sideways into robotics, at a far lower starting cost than a pure-tech entrant.
Where does each automaker stand?
Tesla Optimus has iterated to its Gen 2.5 prototype, targeting limited commercialization in 2026 and volume shipments in 2027 — but dexterous-hand capability remains the key bottleneck.
Hyundai's Boston Dynamics plans 30,000 units of annual capacity by 2028, with over 25,000 units for in-house use. Lee sees Hyundai as the furthest ahead among OEMs.
XPeng's IRON drew attention with a near-human gait, targeting mass production by late 2026 and global delivery in 2027, covering industrial and retail-service scenarios.
Chery's "Mornine" has delivered 220 units globally at roughly RMB 285,800 (~$41,000), available on e-commerce platforms like JD.com — among the first OEM robots shipped at scale.
Why is the factory floor the first proving ground?
BMW deployed humanoid robots at its Spartanburg, USA plant and has used them to help build over 30,000 vehicles, handling high-intensity tasks such as sheet-metal processing.
Starting summer 2026, BMW will expand the pilot to its Leipzig plant in Germany, focusing on battery assembly, in-plant logistics, and parts production.
In plain terms = the automaker's own factory is a ready-made exam hall — clear demand, controlled environment. The robot proves itself on home turf first, then scales outward.
Beyond the factory, where else can these robots go?
Bernstein sketches a commercialization path running from factory → retail → security → public services → home.
Chery's "Mornine" is already deployed in public-safety and medical-guidance roles; GAC's GoMate targets elderly care, security, and industrial use, with trial production in 2026 and mass production in 2027.
This means → blue-collar replacement is not confined to the shop floor. Repetitive service roles — security patrols, reception, guided assistance — are likely the next wave.
What is the real make-or-break milestone?
The report's core call: 2026–2027 is the mass-production window, and the variable that determines whether the timeline holds is dexterous manipulation.
Tesla's Optimus still has not cracked this problem. This reflects a technical gap between "able to walk" and "able to work."
In plain terms = these robots already walk like humans, but precise hand manipulation is not solved yet — whoever clears that bottleneck first turns a prototype into a sellable product.
Content is for reference only, not financial advice.